Schweickart Annalise, Peng Cheng, Zeleznik Oana, Dartora William, Hurd Maurice A, Buga Alex, Kackley Madison L, Clish Clary, McIntire Laura Beth, Volek Jeff S, Makker Vicky, Eliassen A Heather, Goncalves Marcus D, Tamimi Rulla M, Krumsiek Jan
Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
medRxiv. 2025 Aug 24:2025.08.18.25333805. doi: 10.1101/2025.08.18.25333805.
An individual's metabolic state plays a critical role in breast cancer (BC) risk, influenced by factors such as obesity and insulin signaling. Hypocaloric diets induce metabolic changes that influence these metabolic factors, thereby potentially influencing BC risk. However, it remains unclear whether metabolic profiles like those induced by such beneficial diets are associated with BC risk.
We compared the impact of a hypocaloric low-carbohydrate ketogenic diet (KD) and a low-fat diet (LFD) on BC risk in two stages. First, we developed metabolomics-based scores representing the metabolic states resulting from these two hypocaloric diets. Plasma metabolomics data of 43 individuals from two controlled dietary interventions were analyzed (N = 31 KD, N = 12 LFD) and a metabolite-based score was generated for both KD and LFD using diet-induced fold-changes. Second, these scores were applied to metabolomics data from a nested case-control study of participants from the Nurses' Health Study II (NHSII, 1,058 BC cases, 1,054 controls, predominantly premenopausal women). Using multivariable-adjusted models, we assessed the association between the metabolomic scores and BC risk.
KD and LFD had similar but distinct metabolic signatures. Both metabolomics scores were positively associated with breast cancer risk in NHSII. Women in the highest quartile of the KD metabolomic score had a 37% increased risk of BC compared to women in the lowest quartile (p=0.021). Similarly, women in the highest quartile of the LFD metabolomic score had a 32% increased BC risk compared to women in the lowest quartile (p=0.008). Similar increases in risk were seen when further adjusting for BMI at age 18 and weight change since age 18. Increased levels of cholesterol esters (CE), particularly CE 22:6, and long-chain polyunsaturated triglycerides were associated with higher risk in both diet scores, while increases in short-chain, more saturated triglycerides were associated with lower risk.
Metabolomic profiles resembling those induced by hypocaloric ketogenic and low-fat diets were unexpectedly associated with an increased risk of breast cancer in a predominantly premenopausal cohort. These associations were independent of BMI, highlighting the complex relationship between metabolic states and cancer risk, independent of actual dietary interventions.
个体的代谢状态在乳腺癌(BC)风险中起着关键作用,受肥胖和胰岛素信号等因素影响。低热量饮食会引发影响这些代谢因素的代谢变化,从而可能影响乳腺癌风险。然而,尚不清楚像这类有益饮食所诱导的代谢谱是否与乳腺癌风险相关。
我们分两个阶段比较了低热量低碳水化合物生酮饮食(KD)和低脂饮食(LFD)对乳腺癌风险的影响。首先,我们开发了基于代谢组学的评分,以代表这两种低热量饮食所导致的代谢状态。分析了来自两项对照饮食干预的43名个体的血浆代谢组学数据(KD组31人,LFD组12人),并使用饮食诱导的倍数变化为KD和LFD生成了基于代谢物的评分。其次,将这些评分应用于来自护士健康研究II(NHSII,1058例乳腺癌病例,1054例对照,主要为绝经前女性)的巢式病例对照研究的代谢组学数据。使用多变量调整模型,我们评估了代谢组学评分与乳腺癌风险之间的关联。
KD和LFD具有相似但不同的代谢特征。在NHSII中,两种代谢组学评分均与乳腺癌风险呈正相关。KD代谢组学评分最高四分位数的女性与最低四分位数的女性相比,患乳腺癌的风险增加了37%(p = 0.021)。同样,LFD代谢组学评分最高四分位数的女性与最低四分位数的女性相比,患乳腺癌的风险增加了32%(p = 0.008)。在进一步调整18岁时的BMI和自18岁以来的体重变化后,也观察到了类似的风险增加。胆固醇酯(CE)水平升高,特别是CE 22:6,以及长链多不饱和甘油三酯在两种饮食评分中均与较高风险相关,而短链、饱和度更高的甘油三酯增加则与较低风险相关。
在以绝经前人群为主的队列中,类似于低热量生酮饮食和低脂饮食所诱导的代谢组学谱意外地与乳腺癌风险增加相关。这些关联独立于BMI,突出了代谢状态与癌症风险之间复杂的关系,独立于实际的饮食干预。